Bausch Health Companies (BHC) Inventory Average (2010 - 2026)
Bausch Health Companies' (BHC) quarterly Inventory Average came in at $1.6 billion in Q2 2026, down 1.99% year-over-year from $1.6 billion in Q2 2025, and down 0.84% quarter-over-quarter from $1.6 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Inventory Average (2010 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Inventory Average across 17 years of filings, most recently posting $1.6 billion for Q2 2026.
- In Q2 2026, Inventory Average fell 1.99% year-over-year to $1.6 billion; the TTM figure through Jun 2026 stood at $1.6 billion (down 1.99% YoY), while the FY2025 annual figure was $1.6 billion, up 2.71% from the prior year.
- Inventory Average came in at $1.6 billion for Q2 2026 at Bausch Health Companies, down from $1.6 billion in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $1.6 billion in Q2 2025 to a low of $1.0 billion in Q1 2022.
- Average Inventory Average over 5 years is $1.4 billion, with a median of $1.6 billion recorded in 2024.
- Year-over-year, Inventory Average dropped 6.08% in 2022 and jumped 37.54% in 2024.
- Over 5 years, Inventory Average stood at $1.1 billion in 2022, then surged by 31.22% to $1.4 billion in 2023, then grew by 15.41% to $1.6 billion in 2024, then declined by 0.71% to $1.6 billion in 2025, then decreased by 0.74% to $1.6 billion in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $1.6 billion in Q2 2026, $1.6 billion in Q1 2026, and $1.6 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.69 Bn | 2.15 Bn | 3.20 Bn |
| 2 | Viatris | 18.87 Bn | 17.98 Bn | 1.46 Bn | 3.93 Bn |
| 3 | Dr Reddys Laboratories | 9.74 Bn | 9.57 Bn | 396.53 Mn | 843.60 Mn |
| 4 | Amneal Pharmaceuticals | 5.41 Bn | 5.28 Bn | 334.51 Mn | 659.79 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 458.88 Mn | 2.10 Bn | 1.60 Bn |
| 6 | Alvotech | 1.53 Bn | 1.39 Bn | 2.56 Mn | 227.28 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 143.31 Mn |
| 8 | Amphastar Pharmaceuticals | 1.02 Bn | 726.78 Mn | 93.47 Mn | 175.05 Mn |
| 9 | Fennec Pharmaceuticals | 393.81 Mn | 352.56 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 175.97 Mn | 175.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Bn |
| Mar 31, 2026 | 1.62 Bn |
| Dec 31, 2025 | 1.61 Bn |
| Sep 30, 2025 | 1.63 Bn |
| Jun 30, 2025 | 1.63 Bn |
| Mar 31, 2025 | 1.60 Bn |
| Dec 31, 2024 | 1.63 Bn |
| Sep 30, 2024 | 1.63 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.59 Bn |
| Dec 31, 2023 | 1.41 Bn |
| Sep 30, 2023 | 1.26 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Mar 31, 2023 | 1.16 Bn |
| Dec 31, 2022 | 1.07 Bn |
| Sep 30, 2022 | 1.06 Bn |
| Jun 30, 2022 | 1.06 Bn |
| Mar 31, 2022 | 1.02 Bn |
| Dec 31, 2021 | 1.03 Bn |
| Sep 30, 2021 | 1.07 Bn |